483
I.G. RaakFDA 483 - I.G. Raak - November 17, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of I.G. Raak in Jasper, MN, revealed two significant observations related to animal drug use. The firm offered a food-producing animal for interstate commerce with an unapproved drug residue (ciprofloxacin) in edible tissue. Additionally, the firm administered animal drugs contrary to label directions and without a valid veterinary/client/patient relationship, specifically regarding flunixin meglumine and penicillin.
Open in Dashboard
ID · 738fa9bc-df0a-4380-9948-afde038105c0